Depreciation of Fulgent Genetics, Inc. from 30 Jun 2017 to 31 Dec 2025

Taxonomy & unit
us-gaap: USD
Description
The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.
Summary
Fulgent Genetics, Inc. quarterly and annual Depreciation in USD history and change rate from 30 Jun 2017 to 31 Dec 2025.
  • Fulgent Genetics, Inc. Depreciation for the quarter ending 31 Dec 2025 was $4,100,000, a 2.5% increase year-over-year.
  • Fulgent Genetics, Inc. Depreciation for the twelve months ending 31 Dec 2025 was $15,700,000, a 4.3% decline year-over-year.
  • Fulgent Genetics, Inc. annual Depreciation for 2025 was $15,700,000, a 4.3% decline from 2024.
  • Fulgent Genetics, Inc. annual Depreciation for 2024 was $16,400,000, a 6.3% decline from 2023.
  • Fulgent Genetics, Inc. annual Depreciation for 2023 was $17,500,000, a 31% decline from 2022.
Source SEC data
View on sec.gov
Depreciation, Trailing 12 Months (USD)
Depreciation, Quarterly (USD)
Depreciation, YoY Quarterly Change (%)
Depreciation, Annual (USD)
Depreciation, YoY Annual Change (%)

Fulgent Genetics, Inc. Quarterly Depreciation (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q4 2025 $15,700,000 $4,100,000 +$100,000 +2.5% 01 Oct 2025 31 Dec 2025 10-K 27 Feb 2026 2025 FY
Q3 2025 $15,600,000 $3,900,000 +$100,000 +2.6% 01 Jul 2025 30 Sep 2025 10-Q 07 Nov 2025 2025 Q3
Q2 2025 $15,500,000 $3,900,000 -$100,000 -2.5% 01 Apr 2025 30 Jun 2025 10-Q 01 Aug 2025 2025 Q2
Q1 2025 $15,600,000 $3,800,000 -$800,000 -17% 01 Jan 2025 31 Mar 2025 10-Q 02 May 2025 2025 Q1
Q4 2024 $16,400,000 $4,000,000 -$400,000 -9.1% 01 Oct 2024 31 Dec 2024 10-K 27 Feb 2026 2025 FY
Q3 2024 $16,800,000 $3,800,000 -$500,000 -12% 01 Jul 2024 30 Sep 2024 10-Q 07 Nov 2025 2025 Q3
Q2 2024 $17,300,000 $4,000,000 -$100,000 -2.4% 01 Apr 2024 30 Jun 2024 10-Q 01 Aug 2025 2025 Q2
Q1 2024 $17,400,000 $4,600,000 -$100,000 -2.1% 01 Jan 2024 31 Mar 2024 10-Q 02 May 2025 2025 Q1
Q4 2023 $17,500,000 $4,400,000 -$3,200,000 -42% 01 Oct 2023 31 Dec 2023 10-K 27 Feb 2026 2025 FY
Q3 2023 $20,700,000 $4,300,000 -$3,300,000 -43% 01 Jul 2023 30 Sep 2023 10-Q 08 Nov 2024 2024 Q3
Q2 2023 $24,000,000 $4,100,000 -$2,500,000 -38% 01 Apr 2023 30 Jun 2023 10-Q 02 Aug 2024 2024 Q2
Q1 2023 $26,500,000 $4,700,000 +$1,000,000 +27% 01 Jan 2023 31 Mar 2023 10-Q 03 May 2024 2024 Q1
Q4 2022 $25,500,000 $7,600,000 +$5,000,000 +192% 01 Oct 2022 31 Dec 2022 10-K 28 Feb 2025 2024 FY
Q3 2022 $20,500,000 $7,600,000 +$5,100,000 +204% 01 Jul 2022 30 Sep 2022 10-Q 03 Nov 2023 2023 Q3
Q2 2022 $15,400,000 $6,600,000 +$4,300,000 +187% 01 Apr 2022 30 Jun 2022 10-Q 04 Aug 2023 2023 Q2
Q1 2022 $11,100,000 $3,700,000 +$1,800,000 +95% 01 Jan 2022 31 Mar 2022 10-Q 05 May 2023 2023 Q1
Q4 2021 $9,300,000 $2,600,000 +$1,440,000 +124% 01 Oct 2021 31 Dec 2021 10-K 28 Feb 2024 2023 FY
Q3 2021 $7,860,000 $2,500,000 +$1,778,000 +246% 01 Jul 2021 30 Sep 2021 10-Q 07 Nov 2022 2022 Q3
Q2 2021 $6,082,000 $2,300,000 +$1,751,000 +319% 01 Apr 2021 30 Jun 2021 10-Q 04 Aug 2022 2022 Q2
Q1 2021 $4,331,000 $1,900,000 +$1,331,000 +234% 01 Jan 2021 31 Mar 2021 10-Q 05 May 2022 2022 Q1
Q4 2020 $3,000,000 $1,160,000 +$609,000 +111% 01 Oct 2020 31 Dec 2020 10-K 28 Feb 2023 2022 FY
Q3 2020 $2,391,000 $722,000 +$219,000 +44% 01 Jul 2020 30 Sep 2020 10-Q 09 Nov 2021 2021 Q3
Q2 2020 $2,172,000 $549,000 +$38,000 +7.4% 01 Apr 2020 30 Jun 2020 10-Q 10 Aug 2021 2021 Q2
Q1 2020 $2,134,000 $569,000 +$34,000 +6.4% 01 Jan 2020 31 Mar 2020 10-Q 07 May 2021 2021 Q1
Q4 2019 $2,100,000 $551,000 +$13,000 +2.4% 01 Oct 2019 31 Dec 2019 10-K 28 Feb 2022 2021 FY
Q3 2019 $2,087,000 $503,000 -$44,000 -8% 01 Jul 2019 30 Sep 2019 10-Q 09 Nov 2020 2020 Q3
Q2 2019 $2,131,000 $511,000 -$51,000 -9.1% 01 Apr 2019 30 Jun 2019 10-Q 05 Aug 2020 2020 Q2
Q1 2019 $2,182,000 $535,000 +$19,000 +3.7% 01 Jan 2019 31 Mar 2019 10-Q 06 May 2020 2020 Q1
Q4 2018 $2,163,000 $538,000 01 Oct 2018 31 Dec 2018 10-K 13 Mar 2020 2019 FY
Q3 2018 $547,000 +$109,000 +25% 01 Jul 2018 30 Sep 2018 10-Q 08 Nov 2019 2019 Q3
Q2 2018 $562,000 +$157,000 +39% 01 Apr 2018 30 Jun 2018 10-Q 12 Aug 2019 2019 Q2
Q1 2018 $516,000 01 Jan 2018 31 Mar 2018 10-Q 10 May 2019 2019 Q1
Q3 2017 $438,000 01 Jul 2017 30 Sep 2017 10-Q 09 Nov 2018 2018 Q3
Q2 2017 $405,000 01 Apr 2017 30 Jun 2017 10-Q 13 Aug 2018 2018 Q2

Fulgent Genetics, Inc. Annual Depreciation (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2025 $15,700,000 -$700,000 -4.3% 01 Jan 2025 31 Dec 2025 10-K 27 Feb 2026 2025 FY
2024 $16,400,000 -$1,100,000 -6.3% 01 Jan 2024 31 Dec 2024 10-K 27 Feb 2026 2025 FY
2023 $17,500,000 -$8,000,000 -31% 01 Jan 2023 31 Dec 2023 10-K 27 Feb 2026 2025 FY
2022 $25,500,000 +$16,200,000 +174% 01 Jan 2022 31 Dec 2022 10-K 28 Feb 2025 2024 FY
2021 $9,300,000 +$6,300,000 +210% 01 Jan 2021 31 Dec 2021 10-K 28 Feb 2024 2023 FY
2020 $3,000,000 +$900,000 +43% 01 Jan 2020 31 Dec 2020 10-K 28 Feb 2023 2022 FY
2019 $2,100,000 -$63,000 -2.9% 01 Jan 2019 31 Dec 2019 10-K 28 Feb 2022 2021 FY
2018 $2,163,000 +$435,000 +25% 01 Jan 2018 31 Dec 2018 10-K 13 Mar 2020 2019 FY
2017 $1,728,000 01 Jan 2017 31 Dec 2017 10-K 22 Mar 2019 2018 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.